Analysis of expression profiles of MAGE-A antigens in oral squamous cell carcinoma cell lines

Head and Face Medicine

Volumn 5, Issue 1, 2009, Pages

  Müller Richter, Urs D A ^a   Dowejko, Albert ^b   Reuther, Tobias ^a   Kleinheinz, Johannes ^c   Reichert, Torsten E ^b   Driemel, Oliver ^b  

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^b UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^c UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MAGE-A10 ANTIGEN; MAGE-A2 ANTIGEN; MAGEA3 PROTEIN, HUMAN; MAGEA4 PROTEIN, HUMAN; MAGEA6 PROTEIN, HUMAN; MELANOMA ANTIGEN 10; MELANOMA ANTIGEN 2; TUMOR ANTIGEN; TUMOR PROTEIN;

ADULT; ARTICLE; COMPARATIVE STUDY; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMAN; IMMUNOLOGY; MALE; METABOLISM; MOUTH TUMOR; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE;

ADULT; ANTIGENS, NEOPLASM; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MOUTH NEOPLASMS; NEOPLASM PROTEINS;

EID: 67650325134     PISSN: None     EISSN: 1746160X     Source Type: Journal    
DOI: 10.1186/1746-160X-5-10     Document Type: Article

References (25)

1. Immunological ignorance of solid tumors. AF Ochsenbein, Springer Semin Immunopathol 2005 27 1 19 35 10.1007/s00281-004-0192-0 15965711
2. Cancer despite immunosurveillance: immunoselection and immunosubversion. L Zitvogel A Tesniere G Kroemer, Nat Rev Immunol 2006 6 10 715 27 10.1038/nri1936 16977338
3. Progress in head and neck cancer immunotherapy: can tolerance and immune suppression be reversed? RL Ferris, ORL J Otorhinolaryngol Relat Spec 2004 66 6 332 40 15668533
4. Escape from immune surveillance does not result in tolerance to tumor-associated antigens. F Melchionda MK McKirdy F Medeiros TJ Fry CL Mackall, J Immunother 2004 27 5 329 38 10.1097/00002371-200409000-00001 15314541
5. Cancer testis antigenstheir importance in immunotherapy and in the early detection of cancer. A Suri, Expert Opin Biol Ther 2006 6 4 379 89 10.1517/14712598.6.4.379 16548764
6. Cancer/testis antigens, gametogenesis and cancer. AJ Simpson OL Caballero A Jungbluth YT Chen LJ Old, Nat Rev Cancer 2005 5 8 615 25 10.1038/nrc1669 16034368
7. The cancer/testis genes: review, standardization, and commentary. MJ Scanlan AJ Simpson LJ Old, Cancer Immun 2004 4 1 14738373
8. Cancer/testis antigens: an expanding family of targets for cancer immunotherapy. MJ Scanlan AO Gure AA Jungbluth LJ Old YT Chen, Immunol Rev 2002 188 22 32 10.1034/j.1600-065X.2002.18803.x 12445278
9. Cancer/Testis antigens, stem cells and cancer. FF Costa K Le Blanc B Brodin, Stem Cells 2007 25 3 707 11 10.1634/stemcells.2006-0469 17138959
10. Expression of cancer testis antigens in head and neck squamous cell carcinomas. DL Figueiredo RC Mamede R Proto-Siqueira L Neder WA Silva Jr MA Zago, Head Neck 2006 28 7 614 9 10.1002/hed.20380 16475205
11. Identification of NY-ESO-1, MAGE-1, and MAGE-3 in head and neck squamous cell carcinoma. MA Kienstra HB Neel SE Strome P Roche, Head Neck 2003 25 6 457 63 10.1002/hed.10223 12784237
12. Investigation of the expression of melanoma antigen-encoding genes (MAGE-A1 to -A6) in oral squamous cell carcinomas to determine potential targets for gene-based cancer immunotherapy. J Ries S Schultze-Mosgau F Neukam E Diebel J Wiltfang, Int J Oncol 2005 26 3 817 24 15703841
13. Cancer/testis tumour-associated antigens: immunocytochemical detection with monoclonal antibodies. A Juretic GC Spagnoli E Schultz-Thater B Sarcevic, Lancet Oncol 2003 4 2 104 9 10.1016/S1470-2045(03)00982-3 12573352
14. The MAGE proteins: emerging roles in cell cycle progression, apoptosis, and neurogenetic disease. PA Barker A Salehi, J Neurosci Res 2002 67 6 705 12 10.1002/jnr.10160 11891783
15. The p53 tumor suppressor participates in multiple cell cycle checkpoints. LE Giono JJ Manfredi, J Cell Physiol 2006 209 1 13 20 10.1002/jcp.20689 16741928
16. The cancer-testis antigens CT7 (MAGE-C1) and MAGE-A3/6 are commonly expressed in multiple myeloma and correlate with plasma-cell proliferation. AA Jungbluth S Ely M DiLiberto R Niesvizky B Williamson D Frosina YT Chen N Bhardwaj S Chen-Kiang LJ Old HJ Cho, Blood 2005 106 1 167 74 10.1182/blood-2004-12-4931 15761016
17. Overexpression of MAGE/GAGE genes in paclitaxel/doxorubicin-resistant human cancer cell lines. Z Duan Y Duan DE Lamendola RZ Yusuf R Naeem RT Penson MV Seiden, Clin Cancer Res 2003 9 7 2778 85 12855658
18. MAGE-A tumor antigens target p53 transactivation function through histone deacetylase recruitment and confer resistance to chemotherapeutic agents. M Monte M Simonatto LY Peche DR Bublik S Gobessi MA Pierotti M Rodolfo C Schneider, Proc Natl Acad Sci USA 2006 103 30 11160 5 16847267 10.1073/pnas.0510834103
19. Promoter demethylation and histone acetylation mediate gene expression of MAGE-A1, -A2, -A3, and -A12 in human cancer cells. F Wischnewski K Pantel H Schwarzenbach, Mol Cancer Res 2006 4 5 339 49 10.1158/1541-7786.MCR-05-0229 16687489
20. Effects of IFI16 overexpression on the growth and doxorubicin sensitivity of head and neck squamous cell carcinoma-derived cell lines. M De Andrea D Gioia M Mondini B Azzimonti F Reno G Pecorari V Landolfo M Tommasino R Accardi C Herold-Mende S Landolfo M Gariglio, Head Neck 2007 29 9 835 44 10.1002/hed.20611 17510972
21. Reduced stability of retinoblastoma protein by gankyrin, an oncogenic ankyrin-repeat protein overexpressed in hepatomas. H Higashitsuji K Itoh T Nagao S Dawson K Nonoguchi T Kido RJ Mayer S Arii J Fujita, Nat Med 2000 6 1 96 9 10.1038/71600 10613832
22. The oncoprotein gankyrin negatively regulates both p53 and RB by enhancing proteasomal degradation. H Higashitsuji Y Liu RJ Mayer J Fujita, Cell Cycle 2005 4 10 1335 7 16177571
23. Gankyrin: a new oncoprotein and regulator of pRb and p53. S Dawson H Higashitsuji AJ Wilkinson J Fujita RJ Mayer, Trends Cell Biol 2006 16 5 229 33 10.1016/j.tcb.2006.03.001 16581249
24. MAGE-A4 interacts with the liver oncoprotein gankyrin and suppresses its tumorigenic activity. T Nagao H Higashitsuji K Nonoguchi T Sakurai S Dawson RJ Mayer K Itoh J Fujita, J Biol Chem 2003 278 12 10668 74 10.1074/jbc.M206104200 12525503
25. Different Expression of MAGE-A-Antigens in fetal and adult keratinocyte cell lines. UDA Müller-Richter A Dowejko W Zhou TE Reichert O Driemel, Oral Oncol 2008 44 7 628 33 10.1016/j.oraloncology.2007.08.007 17993289